Retatrutide is an investigational weight loss medication still in clinical trials, not yet approved by the FDA
Physiological ROS levels are essential to neuronal functions, such as enhancing synaptic plasticity, long-term potentiation, and memory formation
Quick Answer: Weight loss injections typically do not cause serious heart problems and may reduce cardiovascular events in patients with established heart disease and obesity
2,53,54 Dose and time-dependent reductions in body weight were observed across phase 1 studies and were greater than those observed with dulaglutide 1.5 mg at 29 days both for healthy individuals and for people with T2DM
1 Vitamin B 12 levels greater than 350 pg per mL seem to be protective against symptoms of vitamin B 12 deficiency
41 In diabetes management, a bilayer hydrogel microneedle patch based on polyvinyl alcohol and carboxymethyl chitosan has enabled rapid detection of blood glucose levels through in situ colorimetric analysis